Prot# H3E-US-X020 / NU 05C2: A Phase II Trial of Alimta (Pemetrexed) in Patients with Recurrent Malignant Gliomas, Primary Central Nervous System Lymphoma, and Brain Metastases

Project: Research project

Project Details

StatusFinished
Effective start/end date10/17/052/1/12

Funding

  • Lilly Research Laboratories (H3E-US-X020 / NU 05C2)